公开(公告)号：US20230377686A1

公开(公告)日：2023-11-23

申请号：US18359437

申请日：2023-07-26

申请人： Nantomics LLC ,  NantBio, Inc. ,  Nant Holdings IP, LLC

发明人： Kevin B. Givechian ,  Kamil A. Wnuk ,  Chad Garner ,  Stephen Charles .Benz ,  Hermes J. Garban ,  Shahrooz Rabizadeh ,  Kayvan Niazi ,  Patrick Soon-Shiong

IPC分类号： G16B25/10 ,  C12Q1/6886

CPC分类号： G16B25/10 ,  C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/118 ,  C12Q2600/158

摘要： An immune gene expression signature is associated with favorable clinical features in Treg-enriched tumor samples and can be used to predict immunogenicity of a tumor, overall survival, and/or chemosensitivity.